Predict your next investment

Corporation
HEALTHCARE | Pharmaceuticals / Drugs
supernus.com

See what CB Insights has to offer

Founded Year

1990

Stage

IPO | IPO

Total Raised

$60M

Date of IPO

5/1/2012

Market Cap

1.55B

Stock Price

29.57

Revenue

$0000 

About Supernus Pharmaceuticals

Supernus Pharmaceuticals (NASDAQ: SUPN) develops products for the treatment of central nervous system, or CNS, diseases. The company is developing several product candidates in neurology and psychiatry to address market opportunities in epilepsy and attention deficit hyperactivity disorder, or ADHD, including ADHD patients with impulsive aggression.

Supernus Pharmaceuticals Headquarter Location

9715 Key West Avenue

Rockville, Maryland, 20850,

United States

301-838-2500

Latest Supernus Pharmaceuticals News

Epilepsy Treatment Market 2022 Growth Analysis, Opportunities, Trends, Developments and Forecast to 2029

Jan 13, 2022

Epilepsy Treatment Market 2022 Growth Analysis, Opportunities, Trends, Developments and Forecast to 2029 With the clear understanding of customer requirement, one method or combination of many have been used to construct the most excellent Epilepsy Treatment market survey report. The industry report endows with complete market analysis and forecasting, market definition, market drivers and market restraints, market share, market segmentation and analysis of key players in the market. While preparing report, markets on the local, regional and global level have been explored. Market shares of the key players in the major areas of the globe such as Europe, North America, Asia Pacific, South America, Middle East and Africa is also studied in Epilepsy Treatment market analysis document. Databridge Market Research adds new research Global Epilepsy Treatment Market , which is a detailed analysis of this business space inclusive of the trends, competitive landscape, and the market size. Encompassing one or more parameters among product analysis, application potential, and the regional growth landscape, Global Epilepsy Treatment Market also includes an in-depth study of the industry, competitive scenario. Some of The Major Companies That Are Covered In This Report: Pfizer Inc., Novartis AG, Abbott, Neurelis, GlaxoSmithKline plc, Johnson & Johnson Services Inc., Teva Pharmaceutical Industries Ltd., Sumitomo Dainippon Pharma Co. Ltd, Bausch Health, Sanofi, Takeda Pharmaceutical Company Limited, UCB S.A., Marinus Pharmaceuticals Inc., Eisai Co. Ltd, Upsher-Smith Laboratories LLC, SK BIOPHARMACEUTICALS, Vertex Pharmaceuticals Incorporated, ESTEVE, GW Pharmaceuticals plc, Zogenix Inc., Lundbeck, Supernus Pharmaceuticals Inc and DAIICHI SANKYO COMPANY LIMITED among other domestic and global players. Get Sample Report + All Related Graphs & Charts @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-epilepsy-treatment-market  It offers cautious encounters on the current and past examples of the business which rely upon the events that have occurred around here space and data accumulated from them. The archive further assesses the current business patterns which are needy upon the past data. Also, it offers data on key conditions, for example, the COVID-19 pandemic and its impact on the extensive length and passing impact on the business space. Epilepsy Treatment market report provides CAGR value fluctuation during the forecast period of 2021-2028 for the market. The report provides wide-ranging statistical analysis of the market’s continuous positive developments, capacity, production, production value, cost/profit, supply/demand and import/export. Key elements of this report range from industry outlook along with critical success factors, industry dynamics or market definition in terms of drivers and restraints, market segmentation and value chain analysis, key opportunities or developments, application and technology outlook, regional or country level analysis to competitive landscape. Company market share analysis and key company profiles are the major aspects of competitive analysis which are underlined in the persuasive Epilepsy Treatment market report. This report covers the Global Epilepsy Treatment Market and its development technology dynamics, financial situation, growth strategy, product portfolio, and forecast period. Do not miss out on the trading opportunities at Global Epilepsy Treatment Market. Get key industry insights and help your business grow by talking to our analyst. The Global Epilepsy Treatment Market report not only provided significant value to users, but also presented the market’s wide spectrum of opportunities and threats. Information gleaned from various business models, such as SWOT or PESTEL. The report additionally includes the industry size, share, creation volume, and utilization to acquire experiences about the governmental issues and tussle of dealing with an enormous piece of the portion of the overall industry. The geographic regions and countries covered in the study include: North America, South America, Asia and Pacific Region, Middle east and Africa and Europe. The Key Points of Global Epilepsy Treatment Market – The Global Epilepsy Treatment Market trend study is based upon the CAGR calculated between 2021 and 2028. It includes all information about the market’s top manufacturers, consumers, distributors, and key players. To study the industry’s performance within each region, we determine the Global Epilepsy Treatment Market share as well as its growth rate. This Research report gives a significant wellspring of wise for business tacticians and serious examination of the worldwide market. This conclusive market analysis provides a detailed bifurcation for the global Global Epilepsy Treatment Market , displaying a product segment and product technology as well as a regional segment. A global market analysis provides a snapshot of the competitive image and identity of the Global Epilepsy Treatment Market. This allows for evaluation of key strengths in the industry’s product offerings. The study compiles data that explains the Global Epilepsy Treatment Market’s significance and gives it an edge over its competitors. It also evaluates the market’s end-users to determine the traction and forecast future demand growth. Inquiry before Buying the Report @ https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-epilepsy-treatment-market About Data Bridge Market Research:                          Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Contact:

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Supernus Pharmaceuticals

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Supernus Pharmaceuticals is included in 1 Expert Collection, including Biopharma Tech.

B

Biopharma Tech

15,532 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

Supernus Pharmaceuticals Patents

Supernus Pharmaceuticals has filed 89 patents.

The 3 most popular patent topics include:

  • Amines
  • Piperidines
  • Psychiatric diagnosis
patents chart

Application Date

Grant Date

Title

Related Topics

Status

4/23/2021

11/9/2021

Calcium channel blockers, Pharmacokinetics, Anticonvulsants, Amines, Hepatotoxins

Grant

Application Date

4/23/2021

Grant Date

11/9/2021

Title

Related Topics

Calcium channel blockers, Pharmacokinetics, Anticonvulsants, Amines, Hepatotoxins

Status

Grant

Supernus Pharmaceuticals Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Supernus Pharmaceuticals Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.